Details

Industry: Pharmaceuticals
Type: Business and industry issue
Date: 28/02/2011

Issues Monitor: Pharmaceuticals

Issues Monitor pulls together and shares our firms' industry-wide knowledge to help keep you up-to-date on issues impacting the pharmaceutical sector.

Issues Monitor: Pharmaceuticals - February 2011

The pharmaceuticals industry's current business model for developing blockbusters - one drug suits all, which has been the backbone of its R&D strategy for many years - has stated to change.

Download Now

Issues Monitor: Pharmaceuticals - February 2011 [PDF 540KB]

PDF files require Adobe Reader to view

Download Adobe Reader

This edition focuses on emergence of personalised medicine as a new business opportunity for the pharmaceutical industry.

Contact us

Contact KPMG to find out more about our services or industry experience.

Pharmaceuticals

KPMG’s Pharmaceutical industry practice advises clients with critical business and key industry issues.

Latest articles & publications

	Manufacturing competitiveness in Australia

	Expect the unexpected: Building business value in a changing world

	KPMG International Survey of Corporate Responsibility Reporting 2011



	More articles and publications

Subscribe to related feeds

Pharmaceuticals

© 2013 KPMG, an Australian partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. All rights reserved.

KPMG International Cooperative ("KPMG International") is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.